chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning an unspecified number of patients. The patients' pertinent medical history or drug reactions/allergies were not reported. On unspecified dates from 11-FEB-2015 to 25-JUN-2015, the patients were vaccinated with improperly exposed (Oka/Merck) VARIVAX (subcutaneous, lot: K005427; expiration: 15-APR-2016 and lot: L006383; expiration: 25-FEB-2017 and lot: K005182; expiration: 10-APR-2016 and lot: K005427; expiration: 15-APR-2016 and lot: K015971; expiration: 23-SEP-2016). These vaccines were exposed to 17 Fahrenheit degree for an unspecified length of time. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
itchy (rash on her upper chest and upper back); redness around injection site; rash around injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (itchy (rash on her upper chest and upper back)), INJECTION SITE ERYTHEMA (redness around injection site) and INJECTION SITE RASH (rash around injection site) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0321.20A and 001A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (itchy (rash on her upper chest and upper back)), INJECTION SITE ERYTHEMA (redness around injection site) and INJECTION SITE RASH (rash around injection site). At the time of the report, RASH PRURITIC (itchy (rash on her upper chest and upper back)), INJECTION SITE ERYTHEMA (redness around injection site) and INJECTION SITE RASH (rash around injection site) outcome was unknown.            No concomitant medication were reported No treatment medication were reported. The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable
Patient experienced extreme shortness of breath 16 days after the second Covid-19 vaccination. Treatment was rest and reduction of physical activity. Patient has recovered about 80 % of conditioning level over 3 month period.
pt recvd vax;approx 8 hrs later c/o sore arm at inject site;apap given by mom;5hrs later began staring into space,did not respond to mom voice,followed by jerking w/ lasted approx 40 secs;face & arms turned blue;to er;t 105.7 R;respond meds
Initial report received on 22 January 2010 from a health care professional. This 61 year old female patient who was initially part of a cluster of three patients has a history of hypertension (treated with metoprolol) complained of shoulder pain and injection site pain after receiving FLUZONE SV 2009-2010 (lot number U3377AA) on 25 September 2009. The patient saw an orthopedic twice and was treated with steroid injections without improvement. The patient was not recovered at the time of the report. The other two patients who are a part of this cluster are contained in case numbers 2009-04801 and 2009-04802.
Information has been received regarding a case in litigation concerning a 43 year old female with carpal tunnel syndrome and numbness in hand (both at 15 years of age) who on 12-AUG-1992 was vaccinated with the first dose of RECOMBIVAX HB, a second dose was received but date was not specified. Concomitant medication was not reported. Subsequently on an unspecified date, after the second vaccination with RECOMBIVAX HB, the patient developed multiple sclerosis. The reporter concluded that a "biologically plausible theory connected the vaccine with her injury, a logical sequence of cause and effect, and there was a medically appropriate time frame between vaccination and onset." The outcome of the event was not reported. Upon internal review, multiple sclerosis was considered to be an other important medical event. No further information is available.
Information has been received from a registered nurse concerning a 11 year old male who was vaccinated on 12/7/95 with a dose of varicella virus vaccine live (lot number was unavailable). The patient was seen in June 2003 with pox. The child was noted to have chickenpox breakthrough. Unspecified medical attention was sought. There was no product quality complaint. The reporter indicated that 19 other patients were vaccinated with a dose of varicella virus vaccine live and developed chicken pox breakthrough/shingles (WAES0404USA00205, 0404USA00418, 0404USA00419, 0404USA00420, 0404USA00421, 0404USA00422, 0404USA00423, 0404USA00424, 0404USA00425, 0404USA00426, 0404USA00427, 0404USA00428, 0404USA00429, 0404USA00430, 0404USA00431, 0404USA00432, 0404USA00433, 0404USA00434, 0404USA00435). No further information is expected.
37 y/o received his 2nd anthrax vaccine in his right upper arm on 11 Mar 03 and within 28 hours developed a pruritic, maculopapular, rash "that looks like insect bites" on his arms, legs, and torso. There are no reported systemic symptoms. He denies any change in bath soap, laundry detergent, lotions or any new food or contact substances. He is currently staying in a motel while awaiting deployment. he received anthrax # 1 and typhoid vaccines on 24 Feb without incidence. Pt has no prior history of allergies or chronic diseases, was not ill nor was he taking any medications when he received his vaccination. He has never had an adverse reaction to any vaccine. He is a smoker and occasionally drinks alcohol, but had not had anything to drink before or since the injection. Scattered erythermatous maculopapular lesions- 5-10 ml in size with some nodular in appearance with raised center, small lesions across back of neck and on right wrist in linear presentation. Dermatology consult requested. Picture taken and biopsy performed. Rx Lidex cream AAA tid: Allegra 180mg po qd: Zrytec 10mg po HS
hard abdomen and bloating; diarrhea; Initial information received on 18-Nov-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 65 years old female patient who experienced hard abdomen and bloating (abdominal distension) and diarrhea (diarrhoea), while she received vaccine TYPHOID VI POLYSACCHARIDE VACCINE [TYPHIM VI].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HEPATITIS A VACCINE (HEPATITIS A VACCINE) and HEPATITIS B VACCINE (HEPATITIS B VACCINE).  On 14-Oct-2019, the patient received a 0.5ml dose of suspect TYPHOID VI POLYSACCHARIDE VACCINE lot R2A264M, expiry date: 10-MAY-2021 via intramuscular route in the left deltoid.  On an unknown date, the patient experienced a non-serious hard abdomen and bloating (abdominal distension) and diarrhea (diarrhoea) (Unknown latency) following the administration of TYPHOID VI POLYSACCHARIDE VACCINE.  (Other relevant tests included no lab data.)  Final diagnosis was diarrhea and hard abdomen and bloating.   It was not reported if the patient received a corrective treatment.  The patient outcome was not reported for the events.
itching (itching affected her upper body, face, shoulders and torso).; This is a spontaneous report from a contactable nurse (patient) received via Medical Information Team.  A 30-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249), via an unspecified route of administration at arm left on 13Jan2021 at 12:00 (at the age of 30 years) at single dose for COVID-19 immunization.  Medical history included pregnancy from an unknown date to an unknown date, dual venous thrombosis post pregnancy (from two years and four months ago) and blood thinner from an unknown date and ongoing.  Concomitant medication included warfarin oral at 7.5 mg once a day from an unknown date and ongoing for blood thinner.  The patient experienced itching (itching affected her upper body, face, shoulders and torso). The patient outcome of the event was not recovered.
I had my covid shots, then flew to another location 2 weeks later.  I had 2 events.  Event 1:  About 3 weeks after my 2nd Covid on 3/11/21, I had red bumps on hands, arms, legs.  I went to urgent care .  Dr. didn't know what it was...thought it could be environmental like an allergy.  He gave me Triamcinolone cream.  It cleared up within 2 weeks.  Event 2:   About 6 weeks after the booster, I flew to another location.  I had another outbreak, worse and longer lasting than the first.  My GP,  Dr., thought it might be related to the Covid  vax.   I'm not sure if it was related or not, but thought I should report it just in case.    Currently the bumps have subsided, but they are still visible.
This full body rash itches and burns. PHOTOS OF SIMILAR APPEARING RASHES, AS CAUSED BY COVID19 VACCINES, MAY BE FOUND ON:
Patient reports experiencing tightness in chest while at rest within 2 minutes after receiving vaccine. Pain persisted, 911 was called. BP of 186/96, SPO2 98, HR 92. Patient sweating, appeared very anxious. EKG negative for ST elevation. Patient transported to hospital.
Sick feeling; fever; Up all night because of the fever; Left arm soreness; Headache; Wild dreams; This case was reported by a nurse via call center representative and described the occurrence of feeling unwell in a female patient who received Herpes zoster (Shingrix) (batch number 9X374, expiry date 10th October 2021) for prophylaxis.   On 9th September 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced feeling unwell, fever, sleeplessness, pain in arm, headache and abnormal dreams. On an unknown date, the outcome of the feeling unwell, fever, sleeplessness, pain in arm, headache and abnormal dreams were unknown.   It was unknown if the reporter considered the feeling unwell, fever, sleeplessness, pain in arm, headache and abnormal dreams to be related to Shingrix.  Additional information received were as follows: The nurse also stated that she administered the vaccine to other employees on the day before reporting, who she had called on the reporting date and 7 of the 10 had reported the exact same issues. The nurse did not had the specifics of the individuals other than 4 were females and 3 were males. They all received the same lot and expiration date of the product she received and it was the first dose of Shingrix for all. This case is 1 of the 8 cases, reported by the same reporter.
whole body ache; dizziness; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (whole body ache), DIZZINESS (dizziness) and VACCINATION SITE PAIN (sore arm) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced PAIN (whole body ache), DIZZINESS (dizziness) and VACCINATION SITE PAIN (sore arm). On 16-Mar-2021, PAIN (whole body ache) and VACCINATION SITE PAIN (sore arm) had resolved. On 18-Mar-2021, DIZZINESS (dizziness) had resolved.
Per patient onset of headache at approx 7 pm. She went to bed early and awoke at 1:30 am. She then asked her partner to call for help at hospital she received an MRI - negative. Treated with Morphine which helped.
Headache, body ache, dyspnea, cough, chills, diarrhea, abdominal pain X 8 days  No treatment
Information has been received from a pharmacist referring to a patient of unknown age and gender. Information regarding concomitant medication, medical history and drug reactions/allergies was not reported. On an unknown date, the patient was vaccinated with improperly stored ZOSTAVAX 19400 PFU (lot # M001747 with expiration date 07-APR-2017; dose and route were not reported). No adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.
BUMPS, SWELLING, REDNESS AROUND OUTER MOUTH, AROUND LIPS, PATIENT WAS ADVISED BY PHARMACIST ON DUTY TO SEE HER DOCTOR, PATIENT DOES NOT HAVE A DOCTOR AND HAD NOT SEEING A DOCTOR, PATIENT STARTED TAKING BENADRYL BUT SAYS IT HASN'T DONE MUCH.
The second day after receiving the vaccine, I had painful lymph nodes at the right axillary and left shoulder pain. I took iBuprofen. Five day after, the lymph node pain went away. But, the shoulder pain continued with reduced movement and progressively became worse. I cannot abduct my shoulder as a result.
On 8th day after vaccination, hard lump presented at injection site with intense itching and swelling
Approx. 4 hrs after receiving FLUZONE HD, pt. returned with throat swelling/lump in throat, nausea, rapid shallow breaths. Had her put head down between knees. Gave 50mg diphenhydramine IM. She vomited after about 10 mins & I sent her to emergency room.
Client received HPV vaccine and within 3 minutes client fainted, slumping forward from chair to floor. Provided pillow, ice pack for head, fan and juice to client. Mother was with client.  Vital signs monitored for 1.5 hrs, Mother declined EMS . Vital signs 9:38 AM ---- HR 72 O2 sat 99%,  B/p  100/89       Vital signs 9:40 AM  HR  74,  O2 sat 100%  B/P 94/54,   Vital signs 9:43  AM  HR 78,  O2 sat 100%,  B/P 101/56,  Vital signs 9:58 AM  HR  88,  O2 100%,  B/P 107/68 Mother educated about signs of concussion to continue to observe for at home.
Very large 7inch reddened hard area surrounding shot site, indurated and erythematous with bruising secondary to the induration and swelling.
I began feeling feverish and flu like body symptoms from Tuesday 4/18/06, then knees started getting gradually swollen and painful, swollen fingers and joints, elbows, and pain all over any connecting bone, I then notice a light rash all over body.  Then knees got really swollen to the point I couldn't walk. Right now I can hardly hold anything on my hands because of this weakness and pain on my knuckles.
ears have been burning; she checked her temperature and it is lower than normal, her temperature is usually 96 and she just checked it and it was 91 degrees Fahrenheit; feels like her ears are hot; low iron; it feels like someone is pouring ice on her back/ she finds herself so cold; chills; This is a spontaneous report from a contactable consumer (patient). A 47-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EK9231, expiration date not reported) intramuscular on 30Dec2020 at, single for COVID. The patient had no medical history. There were no concomitant medications. The patient said that calling she was having a side effect that is not on the list of side effect. She does not know if it was from the chills but her ears have been burning ever since had the shot. She feels like her ears were hot. Can the vaccine cause this to happen? She clarified she was not having chills, it doesn't feel like chills, she said on the second day after the vaccine she had chills but right now it felt like someone was pouring ice on her back and she checked her temperature and it is lower than normal, her temperature is usually 96 and she just checked it and it was 91 degrees Fahrenheit. Her ears have been burning. Her first dose was given 30Dec2020. That was another reason she was calling should she get the second dose if she was feeling this way. She said her ears began burning sometime last week and it has not stopped. Sometimes it will go away and come back but she find herself so cold she has to get under the covers and it takes forever to warm up. Today she put a hat and a scarf around her ears to warm up in doors. She has low iron. She doesn't know with her having low iron all her life and she has never experienced this before. Outcome of the event ears have been burning was not recovered while unknown for the other events.
I had a very high fever, body chills, shaking, cold sweats, and every other flu like symptom for two days straight. My fever broke after the 3rd day.
Heart palpitations and slow blood flow on a number of occasions.  Treated by aspirin.
Patient stated feeling numbness on L-cheek followed by tingleness on L side of jaw and numbness on L side of tongue. VS @ 02:55 pm BP 108/66, P 83, Temp 98.4 degree Fahrenheit. VS @ 03:25 pm BP 98/65, P 80 Temp 98.3 degrees Fahrenheit. VS @ 03:55 pm BP 101/65, P 80, Temp 98.2 degrees Fahrenheit.
Two days after vaccine, right leg was painful getting out of bed.  Two days later, started using a cane then a walker.  Went to Urgent care and was scanned for blood clot.  None was present.  About two weeks later went to primary care physician and was x-rayed.  Hip showed arthritis and near bone on bone.  No break was present.  several weeks later saw an orthopedic surgeon.  Thought it was bursitis, and was injected with steroid.  Two weeks later went back and was injected into the groin and hip area.  Pain increased and was intolerable; could not navigate and fell.  Several weeks later went to ER, was x-rayed again,  and hip had fracture.  Surgery for partial hip replacement.  Weakness in hands developed as well a dropped foot.  Also bladder problems. Foot had a burning sensation.  In the hospital for over two weeks to go next to inpatient rehab unit.
Could hardly move right arm for 3 days. Tender at injection sight.  Slight pain in right side of neck for 2 days. Fatigue for 3 days.
Pt recvd 4 doses of Engerix-B & exp nonresponse;
Swelling of throat. difficulty breathing and swallowing. redness in eyes. prednisone was given per patient report.
Shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation concerning to a patient of unknown age and gender.  Information regarding medical history, concurrent conditions and concomitant medications was not provided. In 2012, the patient was inoculated with zoster vaccine live (ZOSTAVAX) at a medical office (dosage regimen, route of administration, lot number and expiration date were not reported) for the long-term prevention of shingles and zoster-related conditions. On an unknown date, the patient was treated by a physician for the following injuries resulting from Plaintiffs ZOSTAVAX use: shingles. As a direct and proximate result of patient's use of the zoster vaccine live (ZOSTAVAX) vaccine, the patient claimed had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of the event of shingles was considered as not recovered. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
I got sick 3 times after the vaccination. I had a sore throat, cough, and running nose. I took a COVID-19 test and it was negative. I was sick for a week, and I fainted. When I fainted, I hit my head. I went to the ER, and they did a COVID-19 rapid test, and it was positive. The day after I went to the ER, I tested negative for COVID-19, and I was still sick for 2-3 weeks more. I am still sick now. I am still testing negative for COVID-19. I also was feeling nauseous and I fainted after the 4th COVID-19 vaccination.
Local injection site reaction: redness, swelling, itchiness. Genital HSV outbreak. Patient states HSV had been previously controlled without incident.
PASSED AWAY; PULMONARY EMBOLISM; This spontaneous report received from a consumer via a company representative through an media concerned a female of unspecified age, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown and expiry: unknown) dose was not reported, 1 total, administered on an unspecified date for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the reporter stated that, "My sister in law unfortunately passed away a week or two after getting the J&J shot. I think it was a pulmonary embolism" On an unspecified date, the patient experienced pulmonary embolism. On an unspecified date, after a week or two weeks following vaccination, the patient died from unknown cause of death. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of unknown cause on an unspecified date and the outcome of pulmonary embolism on an unspecified date. This report was serious (Death, and Other Medically Important Condition). This case, from the same reporter is linked to 20220802964 and 20221156496.; Sender's Comments: V0: 20221157249- Passed away. Insufficient information is available to make a causality assessment. Therefore, this event is considered unclassifiable.  20221157249-pulmonary embolism. The event has a unknown/unclear temporal relationship, and is labeled. There is no information on any other factors potentially associated with the event. Therefore, this event is considered consistent with vaccine administration.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
I received my second Moderna COVID-19 booster on 5/31/2022. I went through menopause at least 9 years prior to this date, but 6/3/2022-6/9/2022, I experienced light-to-medium vaginal bleeding. Ever since then, I experienced it again 6/17/2022-6/21/2022. I have experienced bleeding 7/10/2022-7/12/2022, 8/4/2022-8/9/2022, 9/20/2022-9/27/2022, 10/5/2022-10/5/2022, 11/10/2022-11/11/2022, 12/5/2022-12/9/2022, 12/25/2022-12/28/2022. My gynecologist has put in orders for me to have testing done to make sure the bleeding isn't caused by factors other than the booster shot, but I have not yet done that. On 6/23/2022, I began to experience extreme fatigue. I had just returned from a trip abroad on 6/21/2022, so I attributed it to that. However, my son tested positive for COVID-19, so I underwent a rapid antigen test on 6/27/2022, and the result was positive. During my illness, I experienced fatigue and loss of smell. To the present day, I still can't smell some things. I also had cold-like symptoms, like a runny nose and stuffy nose. I just treated my symptoms with OTC medicines. On or about 6/30/2022, I underwent another rapid antigen test and got a negative result.